INT 2H10
Alternative Names: INT-2H10Latest Information Update: 13 Jan 2023
At a glance
- Originator InteRNA Technologies
- Class MicroRNAs
- Mechanism of Action MicroRNA inhibitors; RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Epilepsy
Most Recent Events
- 10 Jan 2023 InteRNA Technologies has patent protection for miRNA sequences and technologies related to identification of miRNAs, worldwide (InteRNA Technologies, January 2023)
- 06 Jan 2023 Preclinical trials in Epilepsy in Netherlands (Parenteral) (InteRNA Technologies, January 2023)